InvestorsHub Logo

scottsmith

04/07/16 3:38 PM

#195 RE: Joe89 #194

55 for buy out.

Vector93

04/07/16 3:41 PM

#196 RE: Joe89 #194

RLYP has a 6 month head start on the only other hyperkalemia drug on the horizon. It's superior to that drug, and that other drug sold for $2Billion.

The premium for RLYP is much higher than $24.